메뉴 건너뛰기




Volumn 19, Issue 11, 2009, Pages 751-759

Peroxisome proliferator-activated receptors and angiogenesis

Author keywords

Angiogenesis; PPARs; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIDIABETIC AGENT; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

EID: 70449717330     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.04.011     Document Type: Short Survey
Times cited : (61)

References (102)
  • 1
    • 33746080426 scopus 로고    scopus 로고
    • Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics
    • Lemay D.G., and Hwang D.H. Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics. J Lipid Res 47 7 (2006) 1583-1587
    • (2006) J Lipid Res , vol.47 , Issue.7 , pp. 1583-1587
    • Lemay, D.G.1    Hwang, D.H.2
  • 2
    • 16344389190 scopus 로고    scopus 로고
    • Angiogenesis: where do we stand now?
    • Simons M. Angiogenesis: where do we stand now?. Circulation 111 12 (2005) 1556-1566
    • (2005) Circulation , vol.111 , Issue.12 , pp. 1556-1566
    • Simons, M.1
  • 3
    • 11144310564 scopus 로고    scopus 로고
    • An overview on biological mechanisms of PPARs
    • Kota B.P., Huang T.H., and Roufogalis B.D. An overview on biological mechanisms of PPARs. Pharmacol Res 51 2 (2005) 85-94
    • (2005) Pharmacol Res , vol.51 , Issue.2 , pp. 85-94
    • Kota, B.P.1    Huang, T.H.2    Roufogalis, B.D.3
  • 4
    • 0036183630 scopus 로고    scopus 로고
    • The mechanisms of action of PPARs
    • Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 53 (2002) 409-435
    • (2002) Annu Rev Med , vol.53 , pp. 409-435
    • Berger, J.1    Moller, D.E.2
  • 5
    • 0031788318 scopus 로고    scopus 로고
    • Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development
    • Braissant O., and Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 139 6 (1998) 2748-2754
    • (1998) Endocrinology , vol.139 , Issue.6 , pp. 2748-2754
    • Braissant, O.1    Wahli, W.2
  • 6
    • 0030747895 scopus 로고    scopus 로고
    • Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients
    • Auboeuf D., Rieusset J., Fajas L., Vallier P., Frering V., Riou J.P., et al. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46 8 (1997) 1319-1327
    • (1997) Diabetes , vol.46 , Issue.8 , pp. 1319-1327
    • Auboeuf, D.1    Rieusset, J.2    Fajas, L.3    Vallier, P.4    Frering, V.5    Riou, J.P.6
  • 7
    • 0032475922 scopus 로고    scopus 로고
    • Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
    • Chinetti G., Griglio S., Antonucci M., Torra I.P., Delerive P., Majd Z., et al. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273 40 (1998) 25573-25580
    • (1998) J Biol Chem , vol.273 , Issue.40 , pp. 25573-25580
    • Chinetti, G.1    Griglio, S.2    Antonucci, M.3    Torra, I.P.4    Delerive, P.5    Majd, Z.6
  • 8
    • 0032546485 scopus 로고    scopus 로고
    • Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells
    • Inoue I., Shino K., Noji S., Awata T., and Katayama S. Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells. Biochem Biophys Res Commun 246 2 (1998) 370-374
    • (1998) Biochem Biophys Res Commun , vol.246 , Issue.2 , pp. 370-374
    • Inoue, I.1    Shino, K.2    Noji, S.3    Awata, T.4    Katayama, S.5
  • 9
    • 0032565868 scopus 로고    scopus 로고
    • Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
    • Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I.P., et al. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393 6687 (1998) 790-793
    • (1998) Nature , vol.393 , Issue.6687 , pp. 790-793
    • Staels, B.1    Koenig, W.2    Habib, A.3    Merval, R.4    Lebret, M.5    Torra, I.P.6
  • 10
    • 0030835678 scopus 로고    scopus 로고
    • The organization, promoter analysis, and expression of the human PPARgamma gene
    • Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Saladin R., et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272 30 (1997) 18779-18789
    • (1997) J Biol Chem , vol.272 , Issue.30 , pp. 18779-18789
    • Fajas, L.1    Auboeuf, D.2    Raspe, E.3    Schoonjans, K.4    Lefebvre, A.M.5    Saladin, R.6
  • 11
    • 0029152375 scopus 로고
    • Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping
    • Greene M.E., Blumberg B., McBride O.W., Yi H.F., Kronquist K., Kwan K., et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 4 4-5 (1995) 281-299
    • (1995) Gene Expr , vol.4 , Issue.4-5 , pp. 281-299
    • Greene, M.E.1    Blumberg, B.2    McBride, O.W.3    Yi, H.F.4    Kronquist, K.5    Kwan, K.6
  • 12
    • 0029102676 scopus 로고
    • Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms
    • Zhu Y., Qi C., Korenberg J.R., Chen X.N., Noya D., Rao M.S., et al. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci U S A 92 17 (1995) 7921-7925
    • (1995) Proc Natl Acad Sci U S A , vol.92 , Issue.17 , pp. 7921-7925
    • Zhu, Y.1    Qi, C.2    Korenberg, J.R.3    Chen, X.N.4    Noya, D.5    Rao, M.S.6
  • 13
    • 0030590074 scopus 로고    scopus 로고
    • Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2
    • Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M., Moller D.E., et al. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 224 2 (1996) 431-437
    • (1996) Biochem Biophys Res Commun , vol.224 , Issue.2 , pp. 431-437
    • Elbrecht, A.1    Chen, Y.2    Cullinan, C.A.3    Hayes, N.4    Leibowitz, M.5    Moller, D.E.6
  • 14
    • 0028321529 scopus 로고
    • Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
    • Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A 91 15 (1994) 7355-7359
    • (1994) Proc Natl Acad Sci U S A , vol.91 , Issue.15 , pp. 7355-7359
    • Kliewer, S.A.1    Forman, B.M.2    Blumberg, B.3    Ong, E.S.4    Borgmeyer, U.5    Mangelsdorf, D.J.6
  • 15
    • 0027959552 scopus 로고
    • Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators
    • Mukherjee R., Jow L., Noonan D., and McDonnell D.P. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J Steroid Biochem Mol Biol 51 3-4 (1994) 157-166
    • (1994) J Steroid Biochem Mol Biol , vol.51 , Issue.3-4 , pp. 157-166
    • Mukherjee, R.1    Jow, L.2    Noonan, D.3    McDonnell, D.P.4
  • 16
    • 0030218034 scopus 로고    scopus 로고
    • Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2
    • Yoshikawa T., Brkanac Z., Dupont B.R., Xing G.Q., Leach R.J., and Detera-Wadleigh S.D. Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2. Genomics 35 3 (1996) 637-638
    • (1996) Genomics , vol.35 , Issue.3 , pp. 637-638
    • Yoshikawa, T.1    Brkanac, Z.2    Dupont, B.R.3    Xing, G.Q.4    Leach, R.J.5    Detera-Wadleigh, S.D.6
  • 17
    • 0028865305 scopus 로고
    • Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes
    • Jones P.S., Savory R., Barratt P., Bell A.R., Gray T.J., Jenkins N.A., et al. Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes. Eur J Biochem 233 1 (1995) 219-226
    • (1995) Eur J Biochem , vol.233 , Issue.1 , pp. 219-226
    • Jones, P.S.1    Savory, R.2    Barratt, P.3    Bell, A.R.4    Gray, T.J.5    Jenkins, N.A.6
  • 18
    • 0028909362 scopus 로고
    • Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors
    • Amri E.Z., Bonino F., Ailhaud G., Abumrad N.A., and Grimaldi P.A. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 270 5 (1995) 2367-2371
    • (1995) J Biol Chem , vol.270 , Issue.5 , pp. 2367-2371
    • Amri, E.Z.1    Bonino, F.2    Ailhaud, G.3    Abumrad, N.A.4    Grimaldi, P.A.5
  • 19
    • 0033105510 scopus 로고    scopus 로고
    • Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
    • Xu H.E., Lambert M.H., Montana V.G., Parks D.J., Blanchard S.G., Brown P.J., et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3 3 (1999) 397-403
    • (1999) Mol Cell , vol.3 , Issue.3 , pp. 397-403
    • Xu, H.E.1    Lambert, M.H.2    Montana, V.G.3    Parks, D.J.4    Blanchard, S.G.5    Brown, P.J.6
  • 20
    • 0028972025 scopus 로고
    • 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
    • Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 5 (1995) 803-812
    • (1995) Cell , vol.83 , Issue.5 , pp. 803-812
    • Forman, B.M.1    Tontonoz, P.2    Chen, J.3    Brun, R.P.4    Spiegelman, B.M.5    Evans, R.M.6
  • 21
    • 0035844217 scopus 로고    scopus 로고
    • Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists
    • Davies S.S., Pontsler A.V., Marathe G.K., Harrison K.A., Murphy R.C., Hinshaw J.C., et al. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem 276 19 (2001) 16015-16023
    • (2001) J Biol Chem , vol.276 , Issue.19 , pp. 16015-16023
    • Davies, S.S.1    Pontsler, A.V.2    Marathe, G.K.3    Harrison, K.A.4    Murphy, R.C.5    Hinshaw, J.C.6
  • 22
    • 0030952937 scopus 로고    scopus 로고
    • Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
    • Forman B.M., Chen J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A 94 9 (1997) 4312-4317
    • (1997) Proc Natl Acad Sci U S A , vol.94 , Issue.9 , pp. 4312-4317
    • Forman, B.M.1    Chen, J.2    Evans, R.M.3
  • 23
    • 0028802627 scopus 로고
    • Differential activation of peroxisome proliferator-activated receptors by eicosanoids
    • Yu K., Bayona W., Kallen C.B., Harding H.P., Ravera C.P., McMahon G., et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 270 41 (1995) 23975-23983
    • (1995) J Biol Chem , vol.270 , Issue.41 , pp. 23975-23983
    • Yu, K.1    Bayona, W.2    Kallen, C.B.3    Harding, H.P.4    Ravera, C.P.5    McMahon, G.6
  • 24
    • 0013854955 scopus 로고
    • Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat
    • Hess R., Staubli W., and Riess W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 208 5013 (1965) 856-858
    • (1965) Nature , vol.208 , Issue.5013 , pp. 856-858
    • Hess, R.1    Staubli, W.2    Riess, W.3
  • 26
    • 0033998334 scopus 로고    scopus 로고
    • The PPARs: from orphan receptors to drug discovery
    • Willson T.M., Brown P.J., Sternbach D.D., and Henke B.R. The PPARs: from orphan receptors to drug discovery. J Med Chem 43 4 (2000) 527-550
    • (2000) J Med Chem , vol.43 , Issue.4 , pp. 527-550
    • Willson, T.M.1    Brown, P.J.2    Sternbach, D.D.3    Henke, B.R.4
  • 27
    • 0029745382 scopus 로고    scopus 로고
    • Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice
    • Berger J., Bailey P., Biswas C., Cullinan C.A., Doebber T.W., Hayes N.S., et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137 10 (1996) 4189-4195
    • (1996) Endocrinology , vol.137 , Issue.10 , pp. 4189-4195
    • Berger, J.1    Bailey, P.2    Biswas, C.3    Cullinan, C.A.4    Doebber, T.W.5    Hayes, N.S.6
  • 28
    • 0031013395 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs
    • Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., and Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272 6 (1997) 3406-3410
    • (1997) J Biol Chem , vol.272 , Issue.6 , pp. 3406-3410
    • Lehmann, J.M.1    Lenhard, J.M.2    Oliver, B.B.3    Ringold, G.M.4    Kliewer, S.A.5
  • 30
    • 0035942162 scopus 로고    scopus 로고
    • A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
    • Oliver Jr. W.R., Shenk J.L., Snaith M.R., Russell C.S., Plunket K.D., Bodkin N.L., et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 98 9 (2001) 5306-5311
    • (2001) Proc Natl Acad Sci U S A , vol.98 , Issue.9 , pp. 5306-5311
    • Oliver Jr., W.R.1    Shenk, J.L.2    Snaith, M.R.3    Russell, C.S.4    Plunket, K.D.5    Bodkin, N.L.6
  • 31
    • 2442671417 scopus 로고    scopus 로고
    • Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
    • Tenenbaum A., Fisman E.Z., and Motro M. Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovasc Diabetol 2 (2003) 4
    • (2003) Cardiovasc Diabetol , vol.2 , pp. 4
    • Tenenbaum, A.1    Fisman, E.Z.2    Motro, M.3
  • 32
    • 0035993444 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis
    • Vosper H., Khoudoli G.A., Graham T.L., and Palmer C.N. Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis. Pharmacol Ther 95 1 (2002) 47-62
    • (2002) Pharmacol Ther , vol.95 , Issue.1 , pp. 47-62
    • Vosper, H.1    Khoudoli, G.A.2    Graham, T.L.3    Palmer, C.N.4
  • 33
  • 34
    • 33750404258 scopus 로고    scopus 로고
    • Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPar gamma agonism
    • Patel C.B., De Lemos J.A., Wyne K.L., and McGuire D.K. Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPar gamma agonism. Diab Vasc Dis Res 3 2 (2006) 65-71
    • (2006) Diab Vasc Dis Res , vol.3 , Issue.2 , pp. 65-71
    • Patel, C.B.1    De Lemos, J.A.2    Wyne, K.L.3    McGuire, D.K.4
  • 35
    • 0037699955 scopus 로고    scopus 로고
    • Angiogenesis in health and disease
    • Carmeliet P. Angiogenesis in health and disease. Nat Med 9 6 (2003) 653-660
    • (2003) Nat Med , vol.9 , Issue.6 , pp. 653-660
    • Carmeliet, P.1
  • 36
    • 0038037735 scopus 로고    scopus 로고
    • Regulation of angiogenesis by hypoxia: role of the HIF system
    • Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9 6 (2003) 677-684
    • (2003) Nat Med , vol.9 , Issue.6 , pp. 677-684
    • Pugh, C.W.1    Ratcliffe, P.J.2
  • 37
    • 0034094342 scopus 로고    scopus 로고
    • The pathophysiology of the collateral circulation (arteriogenesis)
    • Buschmann I., and Schaper W. The pathophysiology of the collateral circulation (arteriogenesis). J Pathol 190 3 (2000) 338-342
    • (2000) J Pathol , vol.190 , Issue.3 , pp. 338-342
    • Buschmann, I.1    Schaper, W.2
  • 38
    • 8344237449 scopus 로고    scopus 로고
    • Hydroxylation of HIF-1: oxygen sensing at the molecular level
    • Semenza G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19 (2004) 176-182
    • (2004) Physiology (Bethesda) , vol.19 , pp. 176-182
    • Semenza, G.L.1
  • 39
    • 0343920277 scopus 로고    scopus 로고
    • Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    • Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 6573 (1996) 435-439
    • (1996) Nature , vol.380 , Issue.6573 , pp. 435-439
    • Carmeliet, P.1    Ferreira, V.2    Breier, G.3    Pollefeyt, S.4    Kieckens, L.5    Gertsenstein, M.6
  • 41
    • 0030026897 scopus 로고    scopus 로고
    • A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
    • Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15 2 (1996) 290-298
    • (1996) EMBO J , vol.15 , Issue.2 , pp. 290-298
    • Joukov, V.1    Pajusola, K.2    Kaipainen, A.3    Chilov, D.4    Lahtinen, I.5    Kukk, E.6
  • 43
    • 17744396472 scopus 로고    scopus 로고
    • Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
    • Veikkola T., Jussila L., Makinen T., Karpanen T., Jeltsch M., Petrova T.V., et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20 6 (2001) 1223-1231
    • (2001) EMBO J , vol.20 , Issue.6 , pp. 1223-1231
    • Veikkola, T.1    Jussila, L.2    Makinen, T.3    Karpanen, T.4    Jeltsch, M.5    Petrova, T.V.6
  • 44
    • 17044384530 scopus 로고    scopus 로고
    • Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis
    • Lim H.S., Lip G.Y., and Blann A.D. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 180 1 (2005) 113-118
    • (2005) Atherosclerosis , vol.180 , Issue.1 , pp. 113-118
    • Lim, H.S.1    Lip, G.Y.2    Blann, A.D.3
  • 45
    • 0034979273 scopus 로고    scopus 로고
    • Role of vascular endothelial growth factor in regulation of physiological angiogenesis
    • Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280 6 (2001) C1358-C1366
    • (2001) Am J Physiol Cell Physiol , vol.280 , Issue.6
    • Ferrara, N.1
  • 46
    • 0030460424 scopus 로고    scopus 로고
    • Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
    • Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 7 (1996) 1161-1169
    • (1996) Cell , vol.87 , Issue.7 , pp. 1161-1169
    • Davis, S.1    Aldrich, T.H.2    Jones, P.F.3    Acheson, A.4    Compton, D.L.5    Jain, V.6
  • 47
    • 0344450778 scopus 로고    scopus 로고
    • Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
    • Papapetropoulos A., Garcia-Cardena G., Dengler T.J., Maisonpierre P.C., Yancopoulos G.D., and Sessa W.C. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 79 2 (1999) 213-223
    • (1999) Lab Invest , vol.79 , Issue.2 , pp. 213-223
    • Papapetropoulos, A.1    Garcia-Cardena, G.2    Dengler, T.J.3    Maisonpierre, P.C.4    Yancopoulos, G.D.5    Sessa, W.C.6
  • 48
  • 49
    • 0037143737 scopus 로고    scopus 로고
    • Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
    • Lobov I.B., Brooks P.C., and Lang R.A. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A 99 17 (2002) 11205-11210
    • (2002) Proc Natl Acad Sci U S A , vol.99 , Issue.17 , pp. 11205-11210
    • Lobov, I.B.1    Brooks, P.C.2    Lang, R.A.3
  • 50
    • 0035348182 scopus 로고    scopus 로고
    • Plaque angiogenesis and atherosclerosis
    • Moulton K.S. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 3 3 (2001) 225-233
    • (2001) Curr Atheroscler Rep , vol.3 , Issue.3 , pp. 225-233
    • Moulton, K.S.1
  • 51
    • 0037372172 scopus 로고    scopus 로고
    • Abnormal angiogenesis in diabetes mellitus
    • Martin A., Komada M.R., and Sane D.C. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23 2 (2003) 117-145
    • (2003) Med Res Rev , vol.23 , Issue.2 , pp. 117-145
    • Martin, A.1    Komada, M.R.2    Sane, D.C.3
  • 52
    • 33646883882 scopus 로고
    • Clinical and experimental studies on role of oxygen in retrolental fibroplasia
    • Patz A. Clinical and experimental studies on role of oxygen in retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol 58 1 (1954) 45-50
    • (1954) Trans Am Acad Ophthalmol Otolaryngol , vol.58 , Issue.1 , pp. 45-50
    • Patz, A.1
  • 53
    • 0033939404 scopus 로고    scopus 로고
    • Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment
    • Lip P.L., Belgore F., Blann A.D., Hope-Ross M.W., Gibson J.M., and Lip G.Y. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 41 8 (2000) 2115-2119
    • (2000) Invest Ophthalmol Vis Sci , vol.41 , Issue.8 , pp. 2115-2119
    • Lip, P.L.1    Belgore, F.2    Blann, A.D.3    Hope-Ross, M.W.4    Gibson, J.M.5    Lip, G.Y.6
  • 54
    • 0027408091 scopus 로고
    • The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes
    • Nyengaard J.R., and Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 36 3 (1993) 189-194
    • (1993) Diabetologia , vol.36 , Issue.3 , pp. 189-194
    • Nyengaard, J.R.1    Rasch, R.2
  • 55
    • 0031738762 scopus 로고    scopus 로고
    • Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds
    • Loots M.A., Lamme E.N., Zeegelaar J., Mekkes J.R., Bos J.D., and Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 111 5 (1998) 850-857
    • (1998) J Invest Dermatol , vol.111 , Issue.5 , pp. 850-857
    • Loots, M.A.1    Lamme, E.N.2    Zeegelaar, J.3    Mekkes, J.R.4    Bos, J.D.5    Middelkoop, E.6
  • 57
    • 0035895708 scopus 로고    scopus 로고
    • Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications
    • Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49 3 (2001) 554-560
    • (2001) Cardiovasc Res , vol.49 , Issue.3 , pp. 554-560
    • Waltenberger, J.1
  • 58
    • 0027934755 scopus 로고
    • Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry)
    • Barzilay J.I., Kronmal R.A., Bittner V., Eaker E., Evans C., and Foster E.D. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry). Am J Cardiol 74 4 (1994) 334-339
    • (1994) Am J Cardiol , vol.74 , Issue.4 , pp. 334-339
    • Barzilay, J.I.1    Kronmal, R.A.2    Bittner, V.3    Eaker, E.4    Evans, C.5    Foster, E.D.6
  • 59
    • 0026598279 scopus 로고
    • Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material
    • Yarom R., Zirkin H., Stammler G., and Rose A.G. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol 166 3 (1992) 265-270
    • (1992) J Pathol , vol.166 , Issue.3 , pp. 265-270
    • Yarom, R.1    Zirkin, H.2    Stammler, G.3    Rose, A.G.4
  • 60
    • 0032965317 scopus 로고    scopus 로고
    • Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
    • Rivard A., Silver M., Chen D., Kearney M., Magner M., Annex B., et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154 2 (1999) 355-363
    • (1999) Am J Pathol , vol.154 , Issue.2 , pp. 355-363
    • Rivard, A.1    Silver, M.2    Chen, D.3    Kearney, M.4    Magner, M.5    Annex, B.6
  • 61
    • 0029973366 scopus 로고    scopus 로고
    • Distribution of systemically administered ampicillin, benzylpenicillin, and flucloxacillin in excisional wounds in diabetic and normal rats and effects of local topical vasodilator treatment
    • Cross S.E., Thompson M.J., and Roberts M.S. Distribution of systemically administered ampicillin, benzylpenicillin, and flucloxacillin in excisional wounds in diabetic and normal rats and effects of local topical vasodilator treatment. Antimicrob Agents Chemother 40 7 (1996) 1703-1710
    • (1996) Antimicrob Agents Chemother , vol.40 , Issue.7 , pp. 1703-1710
    • Cross, S.E.1    Thompson, M.J.2    Roberts, M.S.3
  • 62
    • 0027385107 scopus 로고
    • Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function
    • Maxfield E.K., Cameron N.E., Cotter M.A., and Dines K.C. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function. Diabetologia 36 12 (1993) 1230-1237
    • (1993) Diabetologia , vol.36 , Issue.12 , pp. 1230-1237
    • Maxfield, E.K.1    Cameron, N.E.2    Cotter, M.A.3    Dines, K.C.4
  • 63
    • 0034038502 scopus 로고    scopus 로고
    • Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy
    • Stevens M.J., Obrosova I., Cao X., Van Huysen C., and Greene D.A. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49 6 (2000) 1006-1015
    • (2000) Diabetes , vol.49 , Issue.6 , pp. 1006-1015
    • Stevens, M.J.1    Obrosova, I.2    Cao, X.3    Van Huysen, C.4    Greene, D.A.5
  • 64
    • 0030774675 scopus 로고    scopus 로고
    • Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
    • Wideroff L., Gridley G., Mellemkjaer L., Chow W.H., Linet M., Keehn S., et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89 18 (1997) 1360-1365
    • (1997) J Natl Cancer Inst , vol.89 , Issue.18 , pp. 1360-1365
    • Wideroff, L.1    Gridley, G.2    Mellemkjaer, L.3    Chow, W.H.4    Linet, M.5    Keehn, S.6
  • 65
    • 0027942607 scopus 로고
    • Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
    • Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 22 (1994) 1480-1487
    • (1994) N Engl J Med , vol.331 , Issue.22 , pp. 1480-1487
    • Aiello, L.P.1    Avery, R.L.2    Arrigg, P.G.3    Keyt, B.A.4    Jampel, H.D.5    Shah, S.T.6
  • 66
    • 0033007062 scopus 로고    scopus 로고
    • Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195
    • Tsuchida K., Makita Z., Yamagishi S., Atsumi T., Miyoshi H., Obara S., et al. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42 5 (1999) 579-588
    • (1999) Diabetologia , vol.42 , Issue.5 , pp. 579-588
    • Tsuchida, K.1    Makita, Z.2    Yamagishi, S.3    Atsumi, T.4    Miyoshi, H.5    Obara, S.6
  • 67
    • 0035085050 scopus 로고    scopus 로고
    • Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair
    • Kampfer H., Pfeilschifter J., and Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 81 3 (2001) 361-373
    • (2001) Lab Invest , vol.81 , Issue.3 , pp. 361-373
    • Kampfer, H.1    Pfeilschifter, J.2    Frank, S.3
  • 68
    • 0242322346 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia
    • Boger R.H., Bode-Boger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 18 (1998) 1842-1847
    • (1998) Circulation , vol.98 , Issue.18 , pp. 1842-1847
    • Boger, R.H.1    Bode-Boger, S.M.2    Szuba, A.3    Tsao, P.S.4    Chan, J.R.5    Tangphao, O.6
  • 70
    • 0033605677 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo
    • Xin X., Yang S., Kowalski J., and Gerritsen M.E. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem 274 13 (1999) 9116-9121
    • (1999) J Biol Chem , vol.274 , Issue.13 , pp. 9116-9121
    • Xin, X.1    Yang, S.2    Kowalski, J.3    Gerritsen, M.E.4
  • 71
    • 0036771776 scopus 로고    scopus 로고
    • PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis
    • Panigrahy D., Singer S., Shen L.Q., Butterfield C.E., Freedman D.A., Chen E.J., et al. PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest 110 7 (2002) 923-932
    • (2002) J Clin Invest , vol.110 , Issue.7 , pp. 923-932
    • Panigrahy, D.1    Singer, S.2    Shen, L.Q.3    Butterfield, C.E.4    Freedman, D.A.5    Chen, E.J.6
  • 72
    • 2142701648 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization
    • Murata T., He S., Hangai M., Ishibashi T., Xi X.P., Kim S., et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Invest Ophthalmol Vis Sci 41 8 (2000) 2309-2317
    • (2000) Invest Ophthalmol Vis Sci , vol.41 , Issue.8 , pp. 2309-2317
    • Murata, T.1    He, S.2    Hangai, M.3    Ishibashi, T.4    Xi, X.P.5    Kim, S.6
  • 73
    • 33644609473 scopus 로고    scopus 로고
    • PPARgamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis
    • Peeters L.L., Vigne J.L., Tee M.K., Zhao D., Waite L.L., and Taylor R.N. PPARgamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis. Angiogenesis 8 4 (2005) 373-379
    • (2005) Angiogenesis , vol.8 , Issue.4 , pp. 373-379
    • Peeters, L.L.1    Vigne, J.L.2    Tee, M.K.3    Zhao, D.4    Waite, L.L.5    Taylor, R.N.6
  • 74
    • 33745424209 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia
    • Chu K., Lee S.T., Koo J.S., Jung K.H., Kim E.H., Sinn D.I., et al. Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res 1093 1 (2006) 208-218
    • (2006) Brain Res , vol.1093 , Issue.1 , pp. 208-218
    • Chu, K.1    Lee, S.T.2    Koo, J.S.3    Jung, K.H.4    Kim, E.H.5    Sinn, D.I.6
  • 75
    • 0034685660 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells
    • Yamakawa K., Hosoi M., Koyama H., Tanaka S., Fukumoto S., Morii H., et al. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. Biochem Biophys Res Commun 271 3 (2000) 571-574
    • (2000) Biochem Biophys Res Commun , vol.271 , Issue.3 , pp. 571-574
    • Yamakawa, K.1    Hosoi, M.2    Koyama, H.3    Tanaka, S.4    Fukumoto, S.5    Morii, H.6
  • 76
    • 0034585795 scopus 로고    scopus 로고
    • Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages
    • Jozkowicz A., Dulak J., Piatkowska E., Placha W., and Dembinska-Kiec A. Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages. Acta Biochim Pol 47 4 (2000) 1147-1157
    • (2000) Acta Biochim Pol , vol.47 , Issue.4 , pp. 1147-1157
    • Jozkowicz, A.1    Dulak, J.2    Piatkowska, E.3    Placha, W.4    Dembinska-Kiec, A.5
  • 77
    • 26244433267 scopus 로고    scopus 로고
    • PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells
    • Pistrosch F., Herbrig K., Oelschlaegel U., Richter S., Passauer J., Fischer S., et al. PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 183 1 (2005) 163-167
    • (2005) Atherosclerosis , vol.183 , Issue.1 , pp. 163-167
    • Pistrosch, F.1    Herbrig, K.2    Oelschlaegel, U.3    Richter, S.4    Passauer, J.5    Fischer, S.6
  • 78
    • 33847674375 scopus 로고    scopus 로고
    • PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts
    • Chintalgattu V., Harris G.S., Akula S.M., and Katwa L.C. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. Cardiovasc Res 74 1 (2007) 140-150
    • (2007) Cardiovasc Res , vol.74 , Issue.1 , pp. 140-150
    • Chintalgattu, V.1    Harris, G.S.2    Akula, S.M.3    Katwa, L.C.4
  • 79
    • 22144441406 scopus 로고    scopus 로고
    • Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation
    • Liu H.B., Hu Y.S., Medcalf R.L., Simpson R.W., and Dear A.E. Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation. Biochem Biophys Res Commun 334 1 (2005) 30-37
    • (2005) Biochem Biophys Res Commun , vol.334 , Issue.1 , pp. 30-37
    • Liu, H.B.1    Hu, Y.S.2    Medcalf, R.L.3    Simpson, R.W.4    Dear, A.E.5
  • 80
    • 33947314469 scopus 로고    scopus 로고
    • Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines
    • Turturro F., Oliver III R., Friday E., Nissim I., and Welbourne T. Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines. Am J Physiol Cell Physiol 292 3 (2007) C1137-C1146
    • (2007) Am J Physiol Cell Physiol , vol.292 , Issue.3
    • Turturro, F.1    Oliver III, R.2    Friday, E.3    Nissim, I.4    Welbourne, T.5
  • 81
    • 13944280963 scopus 로고    scopus 로고
    • Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma
    • Shiau C.W., Yang C.C., Kulp S.K., Chen K.F., Chen C.S., Huang J.W., et al. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma. Cancer Res 65 4 (2005) 1561-1569
    • (2005) Cancer Res , vol.65 , Issue.4 , pp. 1561-1569
    • Shiau, C.W.1    Yang, C.C.2    Kulp, S.K.3    Chen, K.F.4    Chen, C.S.5    Huang, J.W.6
  • 82
    • 7244234089 scopus 로고    scopus 로고
    • Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms
    • Galli A., Ceni E., Crabb D.W., Mello T., Salzano R., Grappone C., et al. Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms. Gut 53 11 (2004) 1688-1697
    • (2004) Gut , vol.53 , Issue.11 , pp. 1688-1697
    • Galli, A.1    Ceni, E.2    Crabb, D.W.3    Mello, T.4    Salzano, R.5    Grappone, C.6
  • 83
    • 15444369845 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress
    • Gardner O.S., Shiau C.W., Chen C.S., and Graves L.M. Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress. J Biol Chem 280 11 (2005) 10109-10118
    • (2005) J Biol Chem , vol.280 , Issue.11 , pp. 10109-10118
    • Gardner, O.S.1    Shiau, C.W.2    Chen, C.S.3    Graves, L.M.4
  • 84
    • 34247623569 scopus 로고    scopus 로고
    • Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells
    • Kim E.H., Na H.K., and Surh Y.J. Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. Ann N Y Acad Sci 1090 (2006) 375-384
    • (2006) Ann N Y Acad Sci , vol.1090 , pp. 375-384
    • Kim, E.H.1    Na, H.K.2    Surh, Y.J.3
  • 85
    • 0028036723 scopus 로고
    • Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element
    • Vu-Dac N., Schoonjans K., Laine B., Fruchart J.C., Auwerx J., and Staels B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem 269 49 (1994) 31012-31018
    • (1994) J Biol Chem , vol.269 , Issue.49 , pp. 31012-31018
    • Vu-Dac, N.1    Schoonjans, K.2    Laine, B.3    Fruchart, J.C.4    Auwerx, J.5    Staels, B.6
  • 86
    • 0345283278 scopus 로고    scopus 로고
    • Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator
    • Scatena R., Bottoni P., Vincenzoni F., Messana I., Martorana G.E., Nocca G., et al. Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator. Chem Res Toxicol 16 11 (2003) 1440-1447
    • (2003) Chem Res Toxicol , vol.16 , Issue.11 , pp. 1440-1447
    • Scatena, R.1    Bottoni, P.2    Vincenzoni, F.3    Messana, I.4    Martorana, G.E.5    Nocca, G.6
  • 87
    • 33748762243 scopus 로고    scopus 로고
    • Fibrates upregulate TRB3 in lymphocytes independent of PPAR alpha by augmenting CCAAT/enhancer-binding protein beta (C/EBP beta) expression
    • Selim E., Frkanec J.T., and Cunard R. Fibrates upregulate TRB3 in lymphocytes independent of PPAR alpha by augmenting CCAAT/enhancer-binding protein beta (C/EBP beta) expression. Mol Immunol 44 6 (2007) 1218-1229
    • (2007) Mol Immunol , vol.44 , Issue.6 , pp. 1218-1229
    • Selim, E.1    Frkanec, J.T.2    Cunard, R.3
  • 89
    • 34047243022 scopus 로고    scopus 로고
    • Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression
    • Wang D., Wang H., Guo Y., Ning W., Katkuri S., Wahli W., et al. Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression. Proc Natl Acad Sci U S A 103 50 (2006) 19069-19074
    • (2006) Proc Natl Acad Sci U S A , vol.103 , Issue.50 , pp. 19069-19074
    • Wang, D.1    Wang, H.2    Guo, Y.3    Ning, W.4    Katkuri, S.5    Wahli, W.6
  • 90
    • 33646269042 scopus 로고    scopus 로고
    • Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis
    • Marin H.E., Peraza M.A., Billin A.N., Willson T.M., Ward J.M., Kennett M.J., et al. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. Cancer Res 66 8 (2006) 4394-4401
    • (2006) Cancer Res , vol.66 , Issue.8 , pp. 4394-4401
    • Marin, H.E.1    Peraza, M.A.2    Billin, A.N.3    Willson, T.M.4    Ward, J.M.5    Kennett, M.J.6
  • 91
    • 47349117843 scopus 로고    scopus 로고
    • Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism
    • Biscetti F., Gaetani E., Flex A., Aprahamian T., Hopkins T., Straface G., et al. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism. Diabetes 57 5 (2008) 1394-1404
    • (2008) Diabetes , vol.57 , Issue.5 , pp. 1394-1404
    • Biscetti, F.1    Gaetani, E.2    Flex, A.3    Aprahamian, T.4    Hopkins, T.5    Straface, G.6
  • 94
    • 34447547870 scopus 로고    scopus 로고
    • Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats
    • Hellmold H., Zhang H., Andersson U., Blomgren B., Holland T., Berg A.L., et al. Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats. Toxicol Sci 98 1 (2007) 63-74
    • (2007) Toxicol Sci , vol.98 , Issue.1 , pp. 63-74
    • Hellmold, H.1    Zhang, H.2    Andersson, U.3    Blomgren, B.4    Holland, T.5    Berg, A.L.6
  • 95
    • 33745957332 scopus 로고    scopus 로고
    • Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study
    • Kendall D.M., Rubin C.J., Mohideen P., Ledeine J.M., Belder R., Gross J., et al. Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study. Diabetes Care 29 5 (2006) 1016-1023
    • (2006) Diabetes Care , vol.29 , Issue.5 , pp. 1016-1023
    • Kendall, D.M.1    Rubin, C.J.2    Mohideen, P.3    Ledeine, J.M.4    Belder, R.5    Gross, J.6
  • 96
    • 33847166204 scopus 로고    scopus 로고
    • Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema?
    • Mittra S., Sangle G., Tandon R., Sharma S., Roy S., Khanna V., et al. Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema?. Br J Pharmacol 150 4 (2007) 480-487
    • (2007) Br J Pharmacol , vol.150 , Issue.4 , pp. 480-487
    • Mittra, S.1    Sangle, G.2    Tandon, R.3    Sharma, S.4    Roy, S.5    Khanna, V.6
  • 97
    • 0842289940 scopus 로고    scopus 로고
    • In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control
    • Pistrosch F., Passauer J., Fischer S., Fuecker K., Hanefeld M., and Gross P. In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care 27 2 (2004) 484-490
    • (2004) Diabetes Care , vol.27 , Issue.2 , pp. 484-490
    • Pistrosch, F.1    Passauer, J.2    Fischer, S.3    Fuecker, K.4    Hanefeld, M.5    Gross, P.6
  • 99
    • 25444522479 scopus 로고    scopus 로고
    • Role of angiogenesis in cardiovascular disease: a critical appraisal
    • Khurana R., Simons M., Martin J.F., and Zachary I.C. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112 12 (2005) 1813-1824
    • (2005) Circulation , vol.112 , Issue.12 , pp. 1813-1824
    • Khurana, R.1    Simons, M.2    Martin, J.F.3    Zachary, I.C.4
  • 100
    • 34250212715 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
    • Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 24 (2007) 2457-2471
    • (2007) N Engl J Med , vol.356 , Issue.24 , pp. 2457-2471
    • Nissen, S.E.1    Wolski, K.2
  • 101
    • 33847006914 scopus 로고    scopus 로고
    • PPAR alpha agonists improve renal preservation in kidneys subjected to chronic in vitro perfusion: interaction with mannitol
    • Jackson T.C., Mi Z., Bastacky S.I., McHale T., Melhem M.F., Sonalker P.A., et al. PPAR alpha agonists improve renal preservation in kidneys subjected to chronic in vitro perfusion: interaction with mannitol. Transpl Int 20 3 (2007) 277-290
    • (2007) Transpl Int , vol.20 , Issue.3 , pp. 277-290
    • Jackson, T.C.1    Mi, Z.2    Bastacky, S.I.3    McHale, T.4    Melhem, M.F.5    Sonalker, P.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.